Insider · CIK 0001976455
Aromando Andrew
Reports to the SEC for 3 companies · SAN DIEGO, CA
Transactions
8
Companies
3
Filings
6
CIK
0001976455
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-01 | ONCYONCOLYTICS BIOTECH INC · Stock OptionA Award | — |
| 2026-02-11 | ONCYONCOLYTICS BIOTECH INCP Purchase | +$25.4K |
| 2024-03-07 | Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-03-07 | Ambrx Biopharma, Inc.Option to Purchase Common StockD Disposition to Issuer | — |
| 2024-03-07 | Ambrx Biopharma, Inc.Restricted Stock UnitsD Disposition to Issuer | — |
| 2023-12-11 | Ambrx Biopharma, Inc.A Award | — |
| 2023-07-05 | Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award | — |
| 2023-04-28 | Ambrx Biopharma Cayman, Inc.Stock Option (right to buy)A Award | — |
Recent filings
- 4Aromando Andrew0001493152-26-027088SEC(opens sec.gov)
- 4Aromando Andrew0001493152-26-006541SEC(opens sec.gov)
- 4Aromando Andrew0000950170-24-028186SEC(opens sec.gov)
- 4Aromando Andrew0000950170-23-069448SEC(opens sec.gov)
- 4Aromando Andrew0000950170-23-032229SEC(opens sec.gov)
- 4Aromando Andrew0000899243-23-012347SEC(opens sec.gov)
Companies
Address
C/O ONCOLYTICS BIOTECH INC. 4350 EXECUTIVE DRIVE, SUITE 325
SAN DIEGO, CA, 92121